WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

FAP INHIBITORS: IN DIABETIC NEPHROPATHY?

Dr. Navneet Omprakash Soni*

ABSTRACT

FAP inhibitor increases the endogenous level of FGF-21which may help in various Metabolic disease, Diabetes and Diabetic complication. Animal model have shown FGF-21 has protected renal damage in Diabetic animal model. However inhibition by FAP inhibitor and raised level of endogenous FGF-21,such raised endogenous FGF-21 have nephroprotective effect have not yet evaluated but FGF-21 mimetic drugs are in trial for Diabetes and metabolic disorder even FGF-21 MIMETICS are not evaluated for Diabetic nephropathy. Probable benefits of FAP inhibitors are highlighted based on evidence and study report.

Keywords: FGF-21, CHD, FAP, FAP Inhibitor, Diabetic Nephropathy.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More